Retroperitoneal mucinous adenocarcinoma occuring during pregnancy in a supernumerary ovary

Journal of Obstetrics and Gynaecology

Volumn 25, Issue 5, 2005, Pages 515-516

  Sonntag, B ^a   Lelle R J ^a   Steinhard, J ^a   Brinkmann, O A ^a   Hungermann, D ^b   Kiesel, L ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; DIAGNOSTIC PROCEDURE; FEMALE; HISTOLOGY; HUMAN; OVARY DISEASE; PREGNANCY; PRIORITY JOURNAL; RETROPERITONEAL TUMOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ADENOCARCINOMA, MUCINOUS; ADULT; FEMALE; HUMANS; OVARIAN NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; RETROPERITONEAL NEOPLASMS;

EID: 31944434711     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/01443610500193478     Document Type: Article

References (4)

1. Kessler TM, Kessler W, Neuweiler J, Nachbur BH. 2002. Treatment of a case of primary retroperitoneal mucinous cystadenocarcinoma: Is adjuvant hysterectomy and bilateral salpingo-oophorectomy justified? American Journal of Obstetrics and Gynecology 187:227-232.
2. Sherard GB, 3rd, Hodson CA, Williams HJ, Semer DA, Hadi HA, Tait DL. 2003. Adnexal masses and pregnancy: a 12-year experience. American Journal of Obstetrics and Gynecology 189: 358-362; discussion 362-353.
3. Trimbos JB, Parmar M, Vergote I, Guthrie D, Bolis G, Colombo N, Vermorken JB, Torri V, Mangioni C, Pecorelli S, et al. 2003. International Collaborative Ovarian Neoplasm trial 1 and Adjuvant Chemotherapy in Ovarian Neoplasm trial: Two parallel randomized phase III trials of adjuvant chemotherapy in patients with early-stage ovarian carcinoma. Journal of the National Cancer Institute 95:105-112.
4. Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H, Sjovall K, et al. 2001. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 357:176-182.